Where does Vincent Brichard work?

Vincent Brichard is Venture Partner at EQT Life Sciences.

What check size does Vincent Brichard write?

Vincent Brichard typically writes checks of $1M – $5M.

Where did Vincent Brichard go to school?

Vincent Brichard studied at Université catholique de Louvain (MD, oncology).

Vincent Brichard

Investor

Venture Partner at EQT Life Sciences

Brussels

Writes $1M – $5M checks · typically $1.5M

Find your path to Vincent

626 people in our graph share verified history with Vincent — schools, employers, funds. One of them is your warm intro.

René KuijtenunlockedVincent: together at EQT Group (2015–2026)

×4Vincent: together at GlaxoSmithKline Biologicals

×5Vincent: together at Harvard Business School

×2Vincent: together at EQT Life Sciences

About

Vincent Brichard is a Venture Partner at EQT Group, a European venture capital firm focused on biotechnology. With over a decade of professional experience, he specializes in clinical trials, oncology, and research and development strategy, supporting portfolio companies in clinical development and strategic initiatives.

Contact· self-published, not guessed

v•••@eqtpartners.comreveal

Experience

EQT GroupVenture Partnercurrent2015 — present
VIANOVA srlFounder & CEOcurrent2014 — present
Solvay Lifelong Learning | Solvay Brussels School of Economics & ManagementProfessor Advanced Master in Biotechnology - Solvaycurrent2022 — present
Fournier-Majoie FoundationScientific & Investment Advisory Boardcurrent2015 — present
atbtherapeuticsIndependent Board member2018 — 2024
ethernaIndependent Board member2016 — 2022
PARACRINE THERAPEUTICSCo-founder&CEO2019 — 2020
ChromaCureChairman of the Board2018 — 2020
Celyad OncologyVice-President Oncology2014 — 2015
GlaxoSmithKline BiologicalsSenior Executive Vice President2002 — 2014GlaxoSmithKline Biologicals
Harvard Business SchoolMBA2012
Université catholique de LouvainProfessor of Oncology2000 — 2002
Institut CurieMedical Oncology Department1998 — 2000
Ludwig Cancer ResearchPHD1990 — 1996

Skills & more

Clinical Trials31Oncology61Biotechnology29Infectious Diseases14Vaccines29Immunology41Medicine18Clinical Development12Life Sciences13Market Access8Drug Development9Diabetes1

+2 more

BiopharmaceuticalsDrug Discovery

Languages English · French

From Vincent's professional profile.

Investments

Investor

ATB TherapeuticsEgle TherapeuticsFoRx TherapeuticsImCheck TherapeuticsMinervaX

Per curated public sources.

Colleagues at EQT Life Sciences

Alex Darden

Partner and Head of EQT Infrastructure Advisory Team Americas & President of EQT Partners Inc at EQT Ventures

Alexandra Edlund

Chief People Officer at EQT Life Sciences

Anne Portwich

Partner at EQT Life Sciences

Arno de Wilde

Investor at EQT Life Sciences

Bert Janssens

Partner, Co-Head of Private Capital at EQT Life Sciences

Bruno Holthof

Partner at EQT Life Sciences

Chris Stone

Investor at EPIC VENTURES

Christina Drews

Chief Operating Officer at EQT Life Sciences

Frequently asked questions

Who is Vincent Brichard?: Vincent Brichard is a Venture Partner at EQT Group, a European venture capital firm focused on biotechnology. With over a decade of professional experience, he specializes in clinical trials, oncology, and research and development strategy, supporting portfolio companies in clinical development and strategic initiatives.
Where does Vincent Brichard work?: Vincent Brichard is Venture Partner at EQT Life Sciences.
What check size does Vincent Brichard write?: Vincent Brichard typically writes checks of $1M – $5M.
What companies has Vincent Brichard invested in?: Investments tracked here include ATB Therapeutics, Egle Therapeutics, FoRx Therapeutics, ImCheck Therapeutics, MinervaX.
Where did Vincent Brichard go to school?: Vincent Brichard studied at Université catholique de Louvain (MD, oncology).